DE1422299U - - Google Patents

Info

Publication number
DE1422299U
DE1422299U DENDAT1422299D DE1422299DU DE1422299U DE 1422299 U DE1422299 U DE 1422299U DE NDAT1422299 D DENDAT1422299 D DE NDAT1422299D DE 1422299D U DE1422299D U DE 1422299DU DE 1422299 U DE1422299 U DE 1422299U
Authority
DE
Germany
Prior art keywords
onkohnüt
9uutbi
0bra
rsnd
dnu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1422299D
Other languages
German (de)
English (en)
Publication of DE1422299U publication Critical patent/DE1422299U/de
Active legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Led Device Packages (AREA)
DENDAT1422299D Active DE1422299U (enExample)

Publications (1)

Publication Number Publication Date
DE1422299U true DE1422299U (enExample)

Family

ID=732035

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1422299D Active DE1422299U (enExample)

Country Status (1)

Country Link
DE (1) DE1422299U (enExample)

Similar Documents

Publication Publication Date Title
BR9908279A (pt) Concentrados retardadores de fogo, métodos para preparação dos mesmos e uso dos mesmos
DE1422299U (enExample)
BR112018002045A2 (pt) composições inibidoras de biofilme que reforçam o ganho de peso em gado
ES2047762T3 (es) Aditivos mejorados para composiciones de cemento hidraulico.
BRPI0417192A (pt) composição imunoestimulante, compreendendo pelo menos um agonista dos receptores toll-like 7 ou do receptor toll-like 8 e um agonista do receptor toll-like 4
MY207057A (en) Rifamycin analogs and antibody-drug conjugates thereof
Štěpánková et al. Lymphatic tissue of the intestinal tract of germfree and conventional rabbits
BR112023005138A2 (pt) Complexo de ligação a egfr e método de preparação e uso do mesmo
BR112023022114A2 (pt) Composto farmacêutico compreendendo agonista de gpr40 e inibidor de sglt-2
BR112021020791A2 (pt) Composição de concreto projetado, processo e estrutura de concreto projetado endurecido
US20150291475A1 (en) Bacterial cell walls as viscosity modifying admixtures of concrete
CL2025001216A1 (es) Compuestos, composiciones y métodos de uso para tratar el hipoparatiroidismo y la osteoporosis
WO2019045195A1 (ko) 콘크리트 조성물
Grabensteiner et al. Differences in the in vitro susceptibility of mono-eukaryotic cultures of Histomonas meleagridis, Tetratrichomonas gallinarum and Blastocystis sp. to natural organic compounds
GB2623253A (en) Klebsiella pneumoniae KlebC polypeptides and uses thereof
KR880007566A (ko) 글리코실화된 글리코펩티드
CY1125862T1 (el) Επιταχυντης πηξης και σκληρυνσης για μια συνθεση τσιμεντου, κονιαματος ή σκυροδεματος, προαιρετικα αποτελουμενος απο συμπληρωματικα τσιμεντοειδη υλικα, και χρηση αυτου του επιταχυντη
US20050031664A1 (en) Porous body with antibiotic coating, method for production, and use
RU2012152257A (ru) Сухая строительная смесь
Jin et al. In vitro antimicrobial susceptibility of Mycoplasma hyorhinis field isolates collected from swine lung specimens in Korea
RU2008104527A (ru) Органоминеральный цемент для специальных работ
Kojić et al. Antimicrobial resistance of Actinobacillus pleuropneumoniae field isolates in autonomus province of Vojvodina, Republic of Serbia
Elliott Removal of Haemonchus contortus, Ostertagia circumcincta and Trichostrongylus spp. from goats, by morantel citrate, levamisole hydrochloride, fenbendazole, and oxfendazole
WO2021236911A8 (en) Lincosamide antibiotics and uses thereof
HRP20120218T1 (hr) Proizvodnja homogenog preparata cjepiva za liječenje raka